Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.

about

Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.

P2860

Q52714390-2BC084FC-5DD0-4CD1-B7E1-A6CA213219D0

P2860

Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.

Item

http://www.wikidata.org/entity/Q39487686

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Her2 oncogene transformation e ...... photodynamic therapy response.

@en

Her2 oncogene transformation e ...... photodynamic therapy response.

@nl

type

Item

label

Her2 oncogene transformation e ...... photodynamic therapy response.

@en

Her2 oncogene transformation e ...... photodynamic therapy response.

@nl

prefLabel

Her2 oncogene transformation e ...... photodynamic therapy response.

@en

Her2 oncogene transformation e ...... photodynamic therapy response.

@nl

P1476

Her2 oncogene transformation e ...... photodynamic therapy response.

@en

P2093

Bin Chen

http://www.w3.org/2001/XMLSchema#string

Chenguang Wang

http://www.w3.org/2001/XMLSchema#string

Kenneth A Myers

http://www.w3.org/2001/XMLSchema#string

Pratheeba Palasuberniam

http://www.w3.org/2001/XMLSchema#string

Xue Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism

Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement

Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid

Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway

Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.

ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial.

Topical photodynamic therapy for dermatologic disorders: results and complications.

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.

Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes

P304

57798-57810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11058

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27527860

http://www.w3.org/2001/XMLSchema#string

P932

5295390

http://www.w3.org/2001/XMLSchema#string

Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.

about

P2860

P2860

Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932